Valuation: Enovis Corporation

Market Cap 1.74B 1.5B 1.4B 1.29B 2.44B 165B 2.46B 16.48B 6.47B 82.65B 6.52B 6.38B 274B P/E 2026 *
252x
P/E 2027 * 31.3x
Enterprise Value 2.94B 2.55B 2.38B 2.19B 4.13B 280B 4.17B 27.93B 10.96B 140B 11.06B 10.81B 464B EV / Sales 2026 *
1.26x
EV / Sales 2027 * 1.14x
Free-Float
98.38%
Yield 2026 *
-
Yield 2027 * -
1 day-2.20%
1 week-0.26%
Current month+3.53%
1 month+34.13%
3 months+25.12%
6 months+38.50%
Current year+13.29%
1 week 28.22
Extreme 28.2158
31.66
1 month 23.32
Extreme 23.315
31.66
Current year 19.14
Extreme 19.14
31.66
1 year 19.14
Extreme 19.14
34.28
3 years 19.14
Extreme 19.14
65.03
5 years 19.14
Extreme 19.14
164.01
10 years 19.14
Extreme 19.14
164.01
Manager TitleAgeSince
Chief Executive Officer 61 11/05/2025
Director of Finance/CFO 47 31/12/2022
Chief Tech/Sci/R&D Officer - 31/12/2025
Director TitleAgeSince
Director/Board Member 55 12/05/2008
Director/Board Member 67 20/09/2010
Chairman 64 20/05/2025
Date Insider Type Main position Quantity % Market Cap.
30/06/26 Free

Director

846 0.0015%
31/03/26 Free

Director

770 0.0013%
07/03/26 Tax

Head of Human Resources

28,555 0.0500%
Change 5-day change 1-year change 3-year change Capi.($)
-2.20%-0.26%+14.06%-49.05% 1.74B
+0.32%-4.32%-11.51%+18.79% 129B
-1.20%-8.73%-16.72%-1.60% 12.56B
+0.23%+5.73%+94.11%+129.68% 10.08B
+0.24%+0.80%-42.81%-68.91% 4.7B
+0.51%-2.30%-18.54%+36.89% 2.63B
-6.31%+17.66%-31.65%-78.32% 1.74B
-2.15%-0.36%-30.54%-32.63% 1.64B
-0.33%-0.71%-16.75%-18.39% 1.67B
Average -1.21%+0.61%-6.70%-7.06% 18.45B
Weighted average by Cap. +0.07%-3.59%-6.67%+19.18%

Financials

2026 *2027 *
Net sales 2.34B 2.03B 1.89B 1.74B 3.29B 223B 3.32B 22.24B 8.73B 112B 8.81B 8.61B 369B 2.47B 2.14B 1.99B 1.83B 3.46B 234B 3.5B 23.4B 9.18B 117B 9.26B 9.06B 389B
Net income 2.98M 2.58M 2.41M 2.21M 4.18M 283M 4.22M 28.27M 11.1M 142M 11.19M 10.95M 470M 54.14M 46.89M 43.71M 40.2M 75.9M 5.15B 76.74M 514M 202M 2.58B 203M 199M 8.53B
Net Debt 1.21B 1.05B 974M 896M 1.69B 115B 1.71B 11.45B 4.49B 57.42B 4.53B 4.43B 190B 1.07B 925M 862M 793M 1.5B 102B 1.51B 10.14B 3.98B 50.82B 4.01B 3.92B 168B
Logo Enovis Corporation
Enovis Corporation is a medical technology company. It is focused on developing clinically differentiated solutions by manufacturing and distributing high-quality medical devices with a range of products used for reconstructive surgery, rehabilitation, pain management and physical therapy. It operates through two segments: Prevention & Recovery and Reconstructive. The Prevention & Recovery segment provides orthopedic and recovery science solutions, including devices, software, and services across the patient care continuum from injury prevention to rehabilitation after surgery, injury, or from degenerative diseases. The Prevention & Recovery products are marketed under several brand names, such as DJO. The Reconstructive segment provides surgical implant solutions, offering a comprehensive suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger and surgical productivity tools. It also operates a Enovis Growth eXcellence business system (EGX).
Employees
7,802
Date Price Change Volume
05/08/26 US$30.18 -2.20% 1,504,408
04/08/26 US$30.86 -1.78% 1,365,675
03/08/26 US$31.42 +7.79% 1,590,536
31/07/26 US$29.15 -0.51% 770,280
30/07/26 US$29.30 -3.17% 869,470
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
13
Last Close Price
30.18USD
Average target price
41.58USD
Spread / Average Target
+37.78%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ENOV Stock